Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 0.1791 Delayed Data As of May 26 |  -0.002 / -1.10%Today’s Change | 0.15 Today|||52-Week Range 2.77 | -84.82% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -8.2M | -8.4M | -24.7M | -22.1M | |
| Depreciation | 27.0K | 23.0K | 62.0K | 283.0K | ||
| Total Other Cash Flow | 2.8M | 1.4M | 6.8M | 66.0K | ||
| Funds From Operations | -5.4M | -7.0M | -17.8M | -21.8M | ||
| Funds From/For Other Operating Expenses | -921.0K | -909.0K | -277.0K | 2.5M | ||
| Net Cash Flow - Operating Activities | -4.5M | -6.1M | -17.6M | -24.3M | ||
| Investing | Increase In Investments | 0.00 | 0.00 | 0.00 | -1.0M | |
| Capital Expenditures | -1.0K | -15.0K | -698.0K | -677.0K | ||
| Net Cash Flow Investing | -1.0K | -15.0K | -698.0K | -1.7M | ||
| Financing | Short Term Borrowings | 3.7M | -300.0K | 0.00 | 0.00 | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 89.0K | 25.8M | 21.1M | 25.1M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 3.8M | 25.5M | 21.1M | 25.1M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -738.0K | 19.4M | 2.8M | -859.0K | ||
